APO-LAMIVUDINE
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is APO-LAMIVUDINE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that APO-LAMIVUDINE 150MG has been permanently discontinued (last updated July 13, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is APO-LAMIVUDINE not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
Other Products
LAMIVUDINE ORAL SOLUTION
AUROBINDO PHARMA LIMITED (UNIT III)
AURO-LAMIVUDINE
AURO PHARMA INC
JAMP LAMIVUDINE HBV
JAMP PHARMA CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02369052
Strength
150MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178